E3G

ESTRONE BETA-D-GLUCURONIDE

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
2 entries where E3G is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	62
Chiral Atom Count	9
Bond Count	66
Aromatic Bond Count	6

2D diagram of E3G

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	ESTRONE BETA-D-GLUCURONIDE
Systematic Name (OpenEye OEToolkits)	(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid
Formula	C₂₄ H₃₀ O₈
Molecular Weight	446.49
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C4C3(C)CCC5c2c(cc(OC1OC(C(=O)O)C(O)C(O)C1O)cc2)CCC5C3CC4
SMILES	CACTVS	3.341	C[C]12CC[CH]3[CH](CCc4cc(O[CH]5O[CH]([CH](O)[CH](O)[CH]5O)C(O)=O)ccc34)[CH]1CCC2=O
SMILES	OpenEye OEToolkits	1.5.0	CC12CCC3c4ccc(cc4CCC3C1CCC2=O)OC5C(C(C(C(O5)C(=O)O)O)O)O
Canonical SMILES	CACTVS	3.341	C[C@]12CC[C@H]3[C@@H](CCc4cc(O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)ccc34)[C@@H]1CCC2=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CCC2=O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O
InChI	InChI	1.03	InChI=1S/C24H30O8/c1-24-9-8-14-13-5-3-12(10-11(13)2-4-15(14)16(24)6-7-17(24)25)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-16,18-21,23,26-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,18+,19+,20-,21+,23-,24+/m1/s1
InChIKey	InChI	1.03	FJAZVHYPASAQKM-JBAURARKSA-N

Related Resource References

Resource Name	Reference
PubChem	115255
ChEMBL	CHEMBL1232444
ChEBI	CHEBI:28919

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.